Anti-CD3 monoclonal antibody
http://dbpedia.org/resource/Anti-CD3_monoclonal_antibody an entity of type: WikicatMonoclonalAntibodies
An anti-CD3 monoclonal antibody is one that binds to CD3 on the surface of T cells. They are immunosuppresive drugs. The first to be approved was muromonab-CD3 in 1986, to treat transplant rejection. Newer monoclonal antibodies with the same mechanism of action include otelixizumab, teplizumab and visilizumab. They are being investigated for the treatment of other conditions like Crohn's disease, ulcerative colitis and type 1 diabetes,and for inducing immune tolerance.
rdf:langString
抗CD3单克隆抗体（Anti-CD3 Monoclonal antibody），是一类T细胞表面CD3的抗体，他们是一类免疫功能抑制药物。 1996年，首批获得批准的药物是莫罗单抗-CD3，其用于治疗移植排斥。 更新的单克隆抗体具有相同的作用机制，产品包括有、和。这些药物用于治疗如克罗恩病、溃疡性结肠炎和1型糖尿病等病变情况，以及进行诱导免疫耐受。
rdf:langString
rdf:langString
Anti-CD3 monoclonal antibody
rdf:langString
抗CD3单克隆抗体
xsd:integer
26571088
xsd:integer
1059588153
rdf:langString
An anti-CD3 monoclonal antibody is one that binds to CD3 on the surface of T cells. They are immunosuppresive drugs. The first to be approved was muromonab-CD3 in 1986, to treat transplant rejection. Newer monoclonal antibodies with the same mechanism of action include otelixizumab, teplizumab and visilizumab. They are being investigated for the treatment of other conditions like Crohn's disease, ulcerative colitis and type 1 diabetes,and for inducing immune tolerance.
rdf:langString
抗CD3单克隆抗体（Anti-CD3 Monoclonal antibody），是一类T细胞表面CD3的抗体，他们是一类免疫功能抑制药物。 1996年，首批获得批准的药物是莫罗单抗-CD3，其用于治疗移植排斥。 更新的单克隆抗体具有相同的作用机制，产品包括有、和。这些药物用于治疗如克罗恩病、溃疡性结肠炎和1型糖尿病等病变情况，以及进行诱导免疫耐受。
xsd:nonNegativeInteger
1769